居家隔离期间的远程药学服务：泰国接受抗病毒治疗的COVID-19患者的药物相关问题及药学照护
Telepharmacy during home isolation: drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand.
作者信息
Sungsana Worapong, Nakaranurack Chotirat, Weeraphon Benjabhorn, Charoenwaiyachet Watsa, Chanprasert Supparat, Torvorapanit Pattama, Santimaleeworagun Wichai, Putcharoen Opass
机构信息
Faculty of Pharmacy, Huachiew Chalermprakiet University, Samut Prakan, Thailand.
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Phayathai Road, Pathumwan, Bangkok, Thailand.
出版信息
J Pharm Policy Pract. 2023 Feb 24;16(1):29. doi: 10.1186/s40545-023-00538-z.
BACKGROUND
Home isolation has been proposed for coronavirus disease 2019 (COVID-19) patients with mild symptoms to avoid hospital overcrowding. This study aimed to describe the drug-related problems (DRPs) and the pharmaceutical care of home-isolating COVID-19 patients in Thailand.
METHODS
Our cross-sectional study was undertaken from July 1 to September 30, 2021, at the King Chulalongkorn Memorial Hospital, Thailand. Patients who were ≥ 18 years old, were diagnosed with mild COVID-19 by real-time polymerase chain reaction (RT-PCR), and were able to isolate at home while receiving an antiviral agent and standard symptomatic treatment were enrolled. Infectious disease pharmacists provided a telepharmacy service on days 1 and 3 after the COVID-19 diagnosis.
RESULTS
A total of 197 patients met the study criteria. Their median age was 45 years, and their most common underlying disease was hypertension (44.29%). All patients exhibited excellent anti-COVID-19 drug adherence. We identified 125 DRPs, including adverse reactions (68%), and the unnecessary use of products (62.40%). Moreover, 91 patients (46.19%) reported the use of supplements or herbs, with vitamin C being the main supplement (37.36%). Pharmacists provided 36 recommendations and received 33 questions from COVID-19 patients.
CONCLUSIONS
Our study demonstrates that telepharmacy is an essential service for detecting and preventing DRPs in home-isolating COVID-19 patients.
背景
对于症状较轻的2019冠状病毒病（COVID-19）患者，建议居家隔离以避免医院过度拥挤。本研究旨在描述泰国居家隔离的COVID-19患者的药物相关问题（DRP）及药学服务。
方法
我们于2021年7月1日至9月30日在泰国朱拉隆功国王纪念医院开展了一项横断面研究。纳入年龄≥18岁、经实时聚合酶链反应（RT-PCR）确诊为轻度COVID-19、在接受抗病毒药物和标准对症治疗的同时能够居家隔离的患者。传染病药剂师在COVID-19诊断后的第1天和第3天提供远程药学服务。
结果
共有197例患者符合研究标准。他们的中位年龄为45岁，最常见的基础疾病是高血压（44.29%）。所有患者对COVID-19药物的依从性都很好。我们识别出125个药物相关问题，包括不良反应（68%）和产品的不必要使用（62.40%）。此外，91例患者（46.19%）报告使用了补充剂或草药，其中维生素C是主要的补充剂（37.36%）。药剂师提供了36条建议，并收到COVID-19患者提出的33个问题。
结论
我们的研究表明，远程药学服务对于检测和预防居家隔离的COVID-19患者的药物相关问题至关重要。
Zotero 插件